MedKoo Cat#: 563330 | Name: MOMIPP
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MOMIPP is a differential inducer of cytoplasmic vacuolization and methuosis.

Chemical Structure

MOMIPP
MOMIPP
CAS#1363421-46-8

Theoretical Analysis

MedKoo Cat#: 563330

Name: MOMIPP

CAS#: 1363421-46-8

Chemical Formula: C18H16N2O2

Exact Mass: 292.1212

Molecular Weight: 292.33

Elemental Analysis: C, 73.95; H, 5.52; N, 9.58; O, 10.95

Price and Availability

Size Price Availability Quantity
100mg USD 450.00 2 Weeks
500mg USD 1,650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
MOMIPP;
IUPAC/Chemical Name
(2E)-3-(5-Methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propen-1-one
InChi Key
UPJCYXIOWHZRLU-GQCTYLIASA-N
InChi Code
InChI=1S/C18H16N2O2/c1-12-15(4-6-18(21)13-7-9-19-10-8-13)16-11-14(22-2)3-5-17(16)20-12/h3-11,20H,1-2H3/b6-4+
SMILES Code
O=C(C1=CC=NC=C1)/C=C/C2=C(C)NC3=C2C=C(OC)C=C3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 292.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Shah KN, Ditto AJ, Crowder DC, Overmeyer JH, Tavana H, Maltese WA, Yun YH. Receptor-Mediated Attachment and Uptake of Hyaluronan Conjugates by Breast Cancer Cells. Mol Pharm. 2017 Nov 6;14(11):3968-3977. doi: 10.1021/acs.molpharmaceut.7b00636. Epub 2017 Oct 19. PubMed PMID: 28981299. 2: Mbah NE, Overmeyer JH, Maltese WA. Disruption of endolysosomal trafficking pathways in glioma cells by methuosis-inducing indole-based chalcones. Cell Biol Toxicol. 2017 Jun;33(3):263-282. doi: 10.1007/s10565-016-9369-2. Epub 2016 Nov 7. PubMed PMID: 27822587; PubMed Central PMCID: PMC5420496. 3: Trabbic CJ, Overmeyer JH, Alexander EM, Crissman EJ, Kvale HM, Smith MA, Erhardt PW, Maltese WA. Synthesis and biological evaluation of indolyl-pyridinyl-propenones having either methuosis or microtubule disruption activity. J Med Chem. 2015 Mar 12;58(5):2489-512. doi: 10.1021/jm501997q. Epub 2015 Feb 19. PubMed PMID: 25654321; PubMed Central PMCID: PMC4360382. 4: Trabbic CJ, Dietsch HM, Alexander EM, Nagy PI, Robinson MW, Overmeyer JH, Maltese WA, Erhardt PW. Differential Induction of Cytoplasmic Vacuolization and Methuosis by Novel 2-Indolyl-Substituted Pyridinylpropenones. ACS Med Chem Lett. 2014 Jan 9;5(1):73-77. PubMed PMID: 24527179; PubMed Central PMCID: PMC3918887. 5: Robinson MW, Overmeyer JH, Young AM, Erhardt PW, Maltese WA. Synthesis and evaluation of indole-based chalcones as inducers of methuosis, a novel type of nonapoptotic cell death. J Med Chem. 2012 Mar 8;55(5):1940-56. doi: 10.1021/jm201006x. Epub 2012 Feb 28. PubMed PMID: 22335538; PubMed Central PMCID: PMC3314534.